001 | 163667 | ||
005 | 20230915090530.0 | ||
024 | 7 | _ | |a pmc:PMC9119264 |2 pmc |
024 | 7 | _ | |a 10.1038/s41556-021-00833-4 |2 doi |
024 | 7 | _ | |a pmid:34983954 |2 pmid |
024 | 7 | _ | |a 1465-7392 |2 ISSN |
024 | 7 | _ | |a 1476-4679 |2 ISSN |
037 | _ | _ | |a DZNE-2022-00413 |
041 | _ | _ | |a English |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Gerber, Julia P |0 P:(DE-2719)9002262 |b 0 |e First author |u dzne |
245 | _ | _ | |a Author Correction: Aberrant chromatin landscape following loss of the H3.3 chaperone Daxx in haematopoietic precursors leads to Pu.1-mediated neutrophilia and inflammation. |
260 | _ | _ | |a New York, NY |c 2022 |b Nature America |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1684852551_10420 |2 PUB:(DE-HGF) |x Erratum/Correction |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a (CC BY) |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
536 | _ | _ | |a 354 - Disease Prevention and Healthy Aging (POF4-354) |0 G:(DE-HGF)POF4-354 |c POF4-354 |f POF IV |x 1 |
536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 2 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
700 | 1 | _ | |a Russ, Jenny |0 P:(DE-2719)2812322 |b 1 |e First author |
700 | 1 | _ | |a Chandrasekar, Vijay |0 P:(DE-2719)2812573 |b 2 |
700 | 1 | _ | |a Offermann, Nina |0 P:(DE-2719)2811777 |b 3 |
700 | 1 | _ | |a Lee, Hang-Mao |0 P:(DE-2719)2814197 |b 4 |
700 | 1 | _ | |a Spear, Sarah |b 5 |
700 | 1 | _ | |a Guzzi, Nicola |b 6 |
700 | 1 | _ | |a Maida, Simona |0 P:(DE-2719)2158371 |b 7 |
700 | 1 | _ | |a Pattabiraman, Sundararaghavan |0 P:(DE-2719)9001263 |b 8 |
700 | 1 | _ | |a Zhang, Ruoyu |0 P:(DE-2719)2812727 |b 9 |
700 | 1 | _ | |a Kayvanjoo, Amir H |b 10 |
700 | 1 | _ | |a Datta, Preeta |b 11 |
700 | 1 | _ | |a Kasturiarachchi, Jagath |b 12 |
700 | 1 | _ | |a Sposito, Teresa |0 P:(DE-2719)9000774 |b 13 |
700 | 1 | _ | |a Izotova, Natalia |b 14 |
700 | 1 | _ | |a Händler, Kristian |0 P:(DE-2719)2812735 |b 15 |
700 | 1 | _ | |a Adams, Peter D |0 0000-0002-0684-1770 |b 16 |
700 | 1 | _ | |a Marafioti, Teresa |b 17 |
700 | 1 | _ | |a Enver, Tariq |0 0000-0002-0866-6443 |b 18 |
700 | 1 | _ | |a Wenzel, Jörg |b 19 |
700 | 1 | _ | |a Beyer, Marc-Daniel |0 P:(DE-2719)2812219 |b 20 |
700 | 1 | _ | |a Mass, Elvira |b 21 |
700 | 1 | _ | |a Bellodi, Cristian |0 0000-0001-8047-5329 |b 22 |
700 | 1 | _ | |a Schultze, Joachim |0 P:(DE-2719)2811660 |b 23 |
700 | 1 | _ | |a Capasso, Melania |0 P:(DE-2719)2811780 |b 24 |
700 | 1 | _ | |a Nimmo, Rachael |b 25 |
700 | 1 | _ | |a Salomoni, Paolo |0 P:(DE-2719)2811779 |b 26 |e Last author |
773 | _ | _ | |a 10.1038/s41556-021-00833-4 |g Vol. 24, no. 1, p. 123 - 123 |0 PERI:(DE-600)1494945-3 |n 1 |p 123 |t Nature cell biology |v 24 |y 2022 |x 1465-7392 |
787 | 0 | _ | |a Gerber, Julia P et.al. |d New York, NY : Nature America, 2021 |i RelatedTo |0 DZNE-2022-00386 |r |t Aberrant chromatin landscape following loss of the H3.3 chaperone Daxx in haematopoietic precursors leads to Pu.1-mediated neutrophilia and inflammation. |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/163667/files/DZNE-2022-00413.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/163667/files/DZNE-2022-00413.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:163667 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)9002262 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2812322 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812573 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2811777 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2814197 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2158371 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)9001263 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2812727 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)9000774 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)2812735 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 20 |6 P:(DE-2719)2812219 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 23 |6 P:(DE-2719)2811660 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 24 |6 P:(DE-2719)2811780 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 26 |6 P:(DE-2719)2811779 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-354 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Prevention and Healthy Aging |x 1 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 2 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-03 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-03 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-03 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-11 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-11 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT CELL BIOL : 2021 |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-11 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-11 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-11 |
915 | _ | _ | |a IF >= 25 |0 StatID:(DE-HGF)9925 |2 StatID |b NAT CELL BIOL : 2021 |d 2022-11-11 |
920 | 1 | _ | |0 I:(DE-2719)1013032 |k AG Salomoni |l Nuclear function in CNS pathophysiology |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1013031 |k AG Schultze |l United epigenomic platform |x 1 |
920 | 1 | _ | |0 I:(DE-2719)5000031 |k R&D PRECISE ; R&D PRECISE |l Platform for Single Cell Genomics and Epigenomics at DZNE & University of Bonn |x 2 |
920 | 1 | _ | |0 I:(DE-2719)1013033 |k AG Capasso |l Immune Regulation |x 3 |
920 | 1 | _ | |0 I:(DE-2719)1013003 |k AG Bano |l Aging and neurodegeneration |x 4 |
920 | 1 | _ | |0 I:(DE-2719)1013035 |k AG Beyer |l Immunogenomics and Neurodegeneration |x 5 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)1013032 |
980 | _ | _ | |a I:(DE-2719)1013031 |
980 | _ | _ | |a I:(DE-2719)5000031 |
980 | _ | _ | |a I:(DE-2719)1013033 |
980 | _ | _ | |a I:(DE-2719)1013003 |
980 | _ | _ | |a I:(DE-2719)1013035 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|